Growth Inhibitory Effects of Ester Derivatives of Menahydroquinone-4, the Reduced Form of Vitamin K(2(20)), on All-Trans Retinoic Acid-Resistant HL60 Cell Line

The first-choice drug for acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA), frequently causes drug-resistance and some adverse effects. Thus, an effective and safe agent for ATRA-resistant APL is needed. Menaquinone-4 (MK-4, vitamin K(2(20))), used for osteoporosis treatment, does...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamakawa, Hirofumi, Setoguchi, Shuichi, Goto, Shotaro, Watase, Daisuke, Terada, Kazuki, Nagata-Akaho, Nami, Toki, Erina, Koga, Mitsuhisa, Matsunaga, Kazuhisa, Karube, Yoshiharu, Takata, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161027/
https://www.ncbi.nlm.nih.gov/pubmed/34065416
http://dx.doi.org/10.3390/pharmaceutics13050758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161027/
https://www.ncbi.nlm.nih.gov/pubmed/34065416
http://dx.doi.org/10.3390/pharmaceutics13050758

Ejemplares similares